BLACKROCK HEALTH SCIENCS TR's ticker is BMEZ and the CUSIP is 09260E105. A total of 83 filers reported holding BLACKROCK HEALTH SCIENCS TR in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,311,953 | +7.8% | 91,045 | +22.8% | 0.00% | 0.0% |
| Q2 2023 | $1,217,161 | +1.4% | 74,127 | +3.4% | 0.00% | 0.0% |
| Q1 2023 | $1,200,458 | +56.9% | 71,712 | +44.5% | 0.00% | 0.0% |
| Q4 2022 | $765,118 | +10.7% | 49,632 | +7.2% | 0.00% | 0.0% |
| Q3 2022 | $691,000 | -3.2% | 46,290 | +7.5% | 0.00% | 0.0% |
| Q2 2022 | $714,000 | +121.7% | 43,075 | +76.2% | 0.00% | +100.0% |
| Q1 2022 | $322,000 | -48.1% | 24,450 | +0.2% | 0.00% | 0.0% |
| Q4 2021 | $621,000 | -10.9% | 24,397 | -5.2% | 0.00% | 0.0% |
| Q3 2021 | $697,000 | +33.0% | 25,745 | +42.4% | 0.00% | 0.0% |
| Q2 2021 | $524,000 | +6.7% | 18,077 | -3.2% | 0.00% | 0.0% |
| Q1 2021 | $491,000 | +0.8% | 18,670 | +9.7% | 0.00% | 0.0% |
| Q4 2020 | $487,000 | +1.9% | 17,012 | -15.0% | 0.00% | 0.0% |
| Q3 2020 | $478,000 | +350.9% | 20,023 | +294.8% | 0.00% | – |
| Q2 2020 | $106,000 | +17.8% | 5,072 | +1.4% | 0.00% | – |
| Q1 2020 | $90,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EPIQ PARTNERS, LLC | 169,250 | $4,451,000 | 2.55% |
| Cornerstone Advisors, LLC | 459,157 | $12,076,000 | 1.06% |
| Matisse Capital | 250,000 | $6,574,000 | 0.95% |
| TRU INDEPENDENCE ASSET MANAGEMENT 2, LLC | 45,356 | $1,193,000 | 0.94% |
| 1607 Capital Partners, LLC | 423,925 | $11,149,000 | 0.54% |
| Thomas J. Herzfeld Advisors, Inc. | 33,722 | $887,000 | 0.40% |
| KAVAR CAPITAL PARTNERS GROUP, LLC | 39,750 | $1,045,000 | 0.28% |
| Stockman Wealth Management, Inc. | 20,296 | $534,000 | 0.15% |
| Karpus Management, Inc. | 186,631 | $4,908,000 | 0.15% |
| CITY OF LONDON INVESTMENT MANAGEMENT CO LTD | 100,211 | $2,631,000 | 0.14% |